Treatment of lung cancer

Abstract

Disclosed are methods of treating lung cancer by administering to a human in need thereof effective amounts of FTS, or various analogs thereof, or a pharmaceutically acceptable salt thereof, optionally, in combination with a chemotherapeutic agent. Chemotherapeutic agents, and combinations thereof, for use with FTS, its analogs, or its salts are also disclosed.

1 . A method of treating a human afflicted with lung cancer, comprising administering to the human an effective amount of FTS or an analog thereof as represented by the formula: 
       
         
           
           
               
               
           
         
         wherein 
         R 1  represents farnesyl or geranyl-geranyl; 
         R 2  represents the groups COOR 7 , CONR 7 R 8 , wherein R 7  and R 8  are each independently hydrogen, alkyl or alkenyl, and COOM wherein M is a cation; 
         R 3 , R 4 , R 5  and R 6  are each independently hydrogen, alkyl, alkenyl, alkoxy, halo, trifluoromethyl, trifluoromethoxy, or alkylmercapto; and 
         X represents S; or a pharmaceutically acceptable salt thereof, and 
         a chemotherapeutic agent comprising pemetrexed. 
       
     
     
         2 . The method of  claim 1 , wherein the human afflicted with lung cancer is administered FTS. 
     
     
         3 . The method of  claim 1 , wherein the human afflicted with lung cancer is administered an analog of FTS which is GGTS. 
     
     
         4 . The method of  claim 1 , wherein FTS or its analog or a pharmaceutically acceptable salt thereof is administered orally. 
     
     
         5 . The method of  claim 4 , wherein the FTS or analog thereof is administered in the form of a tablet or capsule. 
     
     
         6 . The method of  claim 1 , wherein the chemotherapeutic agent is administered intravenously.